The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns ...
The suit accuses the "Big Three" of steering diabetes patients toward high-priced insulin to benefit their bottom lines ...
The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...
In August 2023, the U.S. Department of Health and Human Services announced the first 10 drugs covered under Medicare Part D ...
Weight loss drugs have gained attention as a tool to help combat obesity, but understanding how they work, who they’re for, ...
A new study found a link between SGLT-2 inhibitors and a significantly lower risk of dementia in people with diabetes. Here's ...
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...
Danish drugmaker Novo Nordisk expects its diabetes drug Ozempic will "very likely" be on the U.S. government's 2027 list of ...
Taking a diabetes medication to lower your risk of dementia ... “They are on the gold standard treatment list for congestive heart failure, too,” she says. This study didn’t explore why ...
Lohud.com, Westchester County on MSN5d
Do you want to take Wegovy, Ozempic in New York? Are you taking it now? Tell us your storyNearly 4.4 million adult New Yorkers, or 30%, has obesity, but access to weight-loss medications varies based on a variety of ...
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback